Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Revenue (ASC 606) of $65.3 thousand for fiscal year 2025.
INOVIO PHARMACEUTICALS, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $65.3K | -70.0% |
| 2024 | $217.8K | -73.8% |
| 2023 | $832.0K | -91.9% |
| 2022 | $10.26M | +478.2% |
| 2021 | $1.77M | -76.1% |
| 2020 | $7.41M | +80.2% |
| 2019 | $4.11M | -86.5% |
| 2018 | $30.48M | -27.8% |
| 2017 | $42.22M | +19.4% |
| 2016 | $35.37M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | -100.0% | -100.0% |
| March 31, 2025 | $65.3K | — | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| June 30, 2024 | $100.8K | -55.4% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $388.4K | -95.8% | +71.9% |
| June 30, 2023 | $226.0K | -71.2% | +96.6% |
- INOVIO PHARMACEUTICALS, INC. showed a decrease of -70.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, INOVIO PHARMACEUTICALS, INC.’s revenue (asc 606) has declined by 99.8% (from $35.37 million to $65.3 thousand).
- The most recent figure is from INOVIO PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: